(Reuters) – AstraZeneca said on Tuesday its breast cancer drug, Truqap, in combination with chemotherapy agent, paclitaxel, did not meet its main goals in a late-stage […]

The US Food and Drug Administration (FDA) has expanded the indication for pembrolizumab (Keytruda, Merck) to include the use of the targeted immunotherapy agent plus chemotherapy […]

The US Food and Drug Administration approved blinatumomab (Blincyto — Amgen) as consolidation for CD19-positive, Philadelphia chromosome–negative B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in both children […]

In the field of allergology, desensitization to animals, specifically cats, is rarely prescribed. Has allergen immunotherapy (IT), which has long been considered ineffective, evolved? What other […]

BOSTON — Patients who have had a stroke are thought to be at a higher risk for another one, but oral anticoagulation with edoxaban led to […]

BOSTON — A common stroke risk calculator can help electrophysiologists and cardiologists distinguish which patients with subclinical atrial fibrillation (SCAF) are most likely to benefit from […]

PARIS — A percutaneous intervention strategy based on optical coherence tomography (OCT) provides greater procedural success than an angiography-based strategy for stent optimization in calcified lesions, […]

BOSTON — A Mediterranean diet with extra virgin olive oil (EVOO) significantly reduced the risk for tachyarrhythmia recurrence after atrial fibrillation (AF) ablation in patients with […]

LISBON, Portugal — Few people with suspected heart failure and elevated N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels are receiving a diagnosis after a year, […]